Linear Peptide-Based PET Tracers for Imaging PD-L1 in Tumors

Author:

Zhang Lulu123,Zhang Siqi2,Wu Jiang1,Wang Yanrong1,Wu Yuxuan2,Sun Xiaona2,Wang Xingkai2,Shen Jieting2,Xie Lin3,Zhang Yiding3,Zhang Hailong4,Hu Kuan23ORCID,Wang Feng1,Wang Rui24ORCID,Zhang Ming-Rong3ORCID

Affiliation:

1. Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210008, China

2. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China

3. Department of Advanced Nuclear Medicine Sciences, Institute of Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan

4. Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences & Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Lanzhou University, Lanzhou, Gansu 730000, P. R. China

Funder

Chinese Academy of Medical Sciences

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

National Natural Science Foundation of China

Beijing Nova Program

Nanjing Clinical Medical Center

Nuclear Medicine Laboratory of Mianyang Central Hospital

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3